Cover
About us
Financial highlights
To our shareholders
Can one company make a difference?
Yes, we can...
Helping people with diabetes
Improving global health
Speeding diagnosis of infections
Enhancing pharmaceutical therapies
Pursuing our corporate purpose
Community involvement
Volunteerism
Environmental responsibility
Honoring a legacy
Enterprise Profile:
BD Medical
BD Diagnostics
BD Biosciences
Financials
Financial Review
Financial Statements
Notes to Consolidated Financial Statements
Quarterly Data (unaudited)
Performance Comparison
Corporate Information
Corporate Officers
Board of Directors
Back Cover
Notes to Consolidated Financial Statements
Becton, Dickinson and Company
Thousands of dollars, except per share amounts and numbers of shares
Index
Note
Subject
1
Summary of Significant Accounting Policies
2
Accounting Changes
3
Acquisitions and Divestitures
4
Other Intangible Assets
5
Benefit Plans
6
Income Taxes
7
Supplemental Financial Information
8
Debt
9
Financial Instruments
10
Shareholders Equity
11
Other Comprehensive Income (Loss)
12
Commitments and Contingencies
13
Share-Based Compensation
14
Earnings per Share
15
Segment Data
16
Litigation Settlement and Other Charges